CD4+ Cancer Research Results
CD4+, CD4+ T Cells: Click to Expand ⟱
| Source: |
| Type: |
CD4+ T cells are T lymphocytes that express T cell receptors (TCRs).
Majority of cancer immunotherapies focus on harnessing the anti-tumour CD8+ cytotoxic T cell response, the potential role of CD4+ ‘helper’ T cells has largely remained in the background.
multifaceted role of CD4+ T cells in the anti-tumour immune response.
CD4+ T cells play a critical role in developing and sustaining effective anti-tumour immunity, even in cancer immunotherapies specifically designed to activate a CD8+ CTL response.
|
NA, Not Available: Click to Expand ⟱
Scientific Papers found: Click to Expand⟱
TumCG↓, CD4+↓, CD25+↓, FoxP3+↓, IL4↑,
IL4↓, CD4+↓, CD25+↓, FoxP3+↓, Treg lymp↓,
CD4+↓, CD25+↓, FoxP3+↓, Treg lymp↓, PGE2↓, FOXP3↓, COX2↓,
T-Cell↓, SIRT1↑, CD4+↓,
Showing Research Papers: 1 to 4 of 4
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 4
Pathway results for Effect on Cancer / Diseased Cells:
Core Metabolism/Glycolysis ⓘ
SIRT1↑, 1,
Proliferation, Differentiation & Cell State ⓘ
TumCG↓, 1,
Migration ⓘ
Treg lymp↓, 2,
Immune & Inflammatory Signaling ⓘ
CD25+↓, 3, CD4+↓, 4, COX2↓, 1, FOXP3↓, 1, FoxP3+↓, 3, IL4↓, 1, IL4↑, 1, PGE2↓, 1, T-Cell↓, 1,
Total Targets: 12
Pathway results for Effect on Normal Cells:
Total Targets: 0
Scientific Paper Hit Count for: CD4+, CD4+ T Cells
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:0 Cells:% prod#:% Target#:544 State#:% Dir#:1
wNotes=0 sortOrder:rid,rpid
Home Page